Safety and Immunogenicity of a Mycobacterium Tuberculosis Vaccine M72/AS01E in Participants With Well-controlled HIV (MESA-TB)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04556981 |
|
Recruitment Status :
Completed
First Posted : September 21, 2020
Last Update Posted : June 13, 2023
|
Sponsor:
Bill & Melinda Gates Medical Research Institute
Collaborator:
Wellcome Trust
Information provided by (Responsible Party):
Bill & Melinda Gates Medical Research Institute
- Study Details
- Tabular View
- Results Submitted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | August 12, 2022 |
| Actual Study Completion Date : | August 12, 2022 |
| Submission Cycle | Results Submitted to ClinicalTrials.gov | Results Returned after Quality Control Review |
|---|---|---|
| 1 |
March 15, 2024 |